SecinH3, a specific inhibitor of cytohesin‐2 (ARNO), effectively suppresses Arf6 activation by targeting its Sec7 domain, showing potential applications in diabetes and prostate smooth muscle dysfunction [284]. Here, CYTH2 is linked to diabetes mellitus.